1. Home
  2. STWD vs GKOS Comparison

STWD vs GKOS Comparison

Compare STWD & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STWD

STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

HOLD

Current Price

$18.11

Market Cap

6.4B

Sector

Real Estate

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$121.74

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STWD
GKOS
Founded
2009
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
6.0B
IPO Year
2009
2015

Fundamental Metrics

Financial Performance
Metric
STWD
GKOS
Price
$18.11
$121.74
Analyst Decision
Buy
Strong Buy
Analyst Count
4
14
Target Price
$20.13
$133.07
AVG Volume (30 Days)
2.9M
634.6K
Earning Date
05-08-2026
04-29-2026
Dividend Yield
10.58%
N/A
EPS Growth
4.55
N/A
EPS
1.15
N/A
Revenue
$1,844,289,000.00
$507,442,000.00
Revenue This Year
$283.44
$23.30
Revenue Next Year
$17.66
$27.43
P/E Ratio
$15.78
N/A
Revenue Growth
N/A
32.33
52 Week Low
$16.90
$73.16
52 Week High
$20.99
$130.23

Technical Indicators

Market Signals
Indicator
STWD
GKOS
Relative Strength Index (RSI) 60.90 63.45
Support Level $17.64 $81.54
Resistance Level $18.62 $123.09
Average True Range (ATR) 0.25 4.36
MACD 0.12 1.34
Stochastic Oscillator 91.92 91.89

Price Performance

Historical Comparison
STWD
GKOS

About STWD STARWOOD PROPERTY TRUST INC. Starwood Property Trust Inc.

Starwood Property Trust Inc is a real estate investment trust principally engaged in originating, acquiring, and managing commercial mortgage loans, commercial mortgage-backed securities, and other real estate investments in the U.S., Australia, and Europe. The company has four reportable business segments: Commercial and Residential Lending, Infrastructure Lending, Property, and Investing and Servicing. The majority of its revenue is generated from the Commercial and Residential Lending segment, which engages mainly in originating, acquiring, financing, and managing commercial first mortgages, non-agency residential mortgages (residential loans), commercial mortgage-backed securities (CMBS), residential mortgage-backed securities (RMBS), and other real estate and related debt investments.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: